|
1
|
Bansal V, Kalita J and Misra UK: Diabetic
neuropathy. Postgrad Med J. 82:95–100. 2006.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Kaur S, Pandhi P and Dutta P: Painful
diabetic neuropathy: An update. Ann Neurosci. 18:168–175.
2011.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Román-Pintos LM, Villegas-Rivera G,
Rodríguez-Carrizalez AD, Miranda-Díaz AG and Cardona-Muñoz EG:
Diabetic polyneuropathy in type 2 diabetes mellitus: Inflammation,
oxidative stress, and mitochondrial function. J Diabetes Res.
2016(3425617)2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Dyck PJ, Kratz KM, Karnes JL, Litchy WJ,
Klein R, Pach JM, Wilson DM, O'Brien PC, Melton LJ III and Service
FJ: The prevalence by staged severity of various types of diabetic
neuropathy, retinopathy, and nephropathy in a population-based
cohort: The rochester diabetic neuropathy study. Neurology.
43:817–824. 1993.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Young MJ, Boulton AJ, MacLeod AF, Williams
DR and Sonksen PH: A multicentre study of the prevalence of
diabetic peripheral neuropathy in the United Kingdom hospital
clinic population. Diabetologia. 36:150–154. 1993.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Jaiswal M, Lauer A, Martin CL, Bell RA,
Divers J, Dabelea D, Pettitt DJ, Saydah S, Pihoker C, Standiford
DA, et al: SEARCH for Diabetes in Youth Study Group: Peripheral
neuropathy in adolescents and young adults with type 1 and type 2
diabetes from the SEARCH for Diabetes in Youth follow-up cohort: A
pilot study. Diabetes Care. 36:3903–3908. 2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Veresiu AI, Bondor CI, Florea B, Vinik EJ,
Vinik AI and Gâvan NA: Detection of undisclosed neuropathy and
assessment of its impact on quality of life: A survey in 25,000
Romanian patients with diabetes. J Diabetes Complications.
29:644–649. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Pop-Busui R, Boulton AJ, Feldman EL, Bril
V, Freeman R, Malik RA, Sosenko JM and Ziegler D: Diabetic
neuropathy: A position statement by the American diabetes
association. Diabetes Care. 40:136–154. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Vinik AI: Advances in diabetes for the
millennium: New treatments for diabetic neuropathies. MedGenMed. 6
(3 Suppl)(S13)2004.PubMed/NCBI
|
|
10
|
Rathmann W, Ziegler D, Jahnke M, Haastert
B and Gries FA: Mortality in diabetic patients with cardiovascular
autonomic neuropathy. Diabet Med. 10:820–824. 1993.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Bansal D, Gudala K, Muthyala H, Esam HP,
Nayakallu R and Bhansali A: Prevalence and risk factors of
development of peripheral diabetic neuropathy in type 2 diabetes
mellitus in a tertiary care setting. J Diabetes Investig.
5:714–721. 2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Diabetes Control and Complications Trial
Research Group. Nathan DM, Genuth S, Lachin J, Cleary P, Crofford
O, Davis M, Rand L and Siebert C: The effect of intensive treatment
of diabetes on the development and progression of long-term
complications in insulin-dependent diabetes mellitus. N Engl J Med.
329:977–986. 1993.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Klein R, Klein BE and Moss SE: Relation of
glycemic control to diabetic microvascular complications in
diabetes mellitus. Ann Intern Med. 124:90–96. 1996.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Tesfaye S, Chaturvedi N, Eaton SE, Ward
JD, Manes C, Ionescu-Tirgoviste C, Witte DR and Fuller JH: EURODIAB
Prospective Complications Study Group. Vascular risk factors and
diabetic neuropathy. N Engl J Med. 352:341–350. 2005.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Action to Control Cardiovascular Risk in
Diabetes Study Group. Gerstein HC, Miller ME, Byington RP, Goff DC
Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, et
al: Effects of intensive glucose lowering in type 2 diabetes. N
Engl J Med. 358:2545–2559. 2008.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Callaghan BC, Little AA, Feldman EL and
Hughes RA: Enhanced glucose control for preventing and treating
diabetic neuropathy. Cochrane Database Syst Rev.
6(CD007543)2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ismail-Beigi F, Craven T, Banerji MA,
Basile J, Calles J, Cohen RM, Cuddihy R, Cushman WC, Genuth S,
Grimm RH Jr, et al: Effect of intensive treatment of hyperglycaemia
on microvascular outcomes in type 2 diabetes: An analysis of the
ACCORD randomized trial. Lancet. 376:419–430. 2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Gaede P, Vedel P, Larsen N, Jensen GV,
Parving HH and Pedersen O: Multifactorial intervention and
cardiovascular disease in patients with type 2 diabetes. N Engl J
Med. 348:383–393. 2003.PubMed/NCBI View Article : Google Scholar
|
|
19
|
BARI 2D Study Group. Frye RL, August P,
Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, Orchard TJ,
Chaitman BR, Genuth SM, et al: A randomized trial of therapies for
type 2 diabetes and coronary artery disease. N Engl J Med.
360:2503–2515. 2009.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Ardeleanu V, Toma A, Pafili K, Papanas N,
Motofei I, Diaconu CC, Rizzo M and Stoian AP: Current
pharmacological treatment of painful diabetic neuropathy: A
narrative review. Medicina (Kaunas). 56(25)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Gregory JA, Jolivalt CG, Goor J, Mizisin
AP and Calcutt NA: Hypertension-induced peripheral neuropathy and
the combined effects of hypertension and diabetes on nerve
structure and function in rats. Acta Neuropathol. 124:561–573.
2012.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Elliott J, Tesfaye S, Chaturvedi N, Gandhi
RA, Stevens LK, Emery C and Fuller JH: EURODIAB Prospective
Complications Study Group: Large-fiber dysfunction in diabetic
peripheral neuropathy is predicted by cardiovascular risk factors.
Diabetes Care. 32:1896–1900. 2009.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Perez-Matos MC, Morales-Alvarez MC and
Mendivil CO: Lipids: A suitable therapeutic target in diabetic
neuropathy? J Diabetes Res. 2017(6943851)2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Clair C, Cohen MJ, Eichler F, Selby KJ and
Rigotti NA: The effect of cigarette smoking on diabetic peripheral
neuropathy: A systematic review and meta-analysis. J Gen Intern
Med. 30:1193–1203. 2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Papanas N and Ziegler D: Risk factors and
comorbidities in diabetic neuropathy: An update 2015. Rev Diabet
Stud. 12:48–62. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Tesfaye S, Stevens LK, Stephenson JM,
Fuller JH, Plater M, Ionescu-Tirgoviste C, Nuber A, Pozza G and
Ward JD: Prevalence of diabetic peripheral neuropathy and its
relation to glycaemic control and potential risk factors: The
EURODIAB IDDM complications study. Diabetologia. 39:1377–1384.
1996.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Mazilu L, Stanculeanu DL, Gheorghe AD,
Suceveanu AP, Parepa IR, Stoian Pantea A and Suceveanu AI: Clinical
impact of association between diabetes and lung cancer. Rev Chim.
70:1149–1151. 2019.
|
|
28
|
Suceveanu AI, Suceveanu AP, Gheorghe AD
and Mazilu L: Diabetes and cancer-is there a link? In: Diabetes and
its complications, Gaber AR (ed). InTech, pp119-137, 2017.
|
|
29
|
Suceveanu AI, Mazilu L, Nitipir C, Stoian
AP, Parepa I, Voinea C and Suceveanu AP: Diabetes mellitus raise
the risk for interval colorectal cancer and advanced adenomas. Rev
Chim. 70:1808–1811. 2019.
|
|
30
|
Mazilu L, Stanculeanu DL, Gheorghe AD,
Voinea F, Suceveanu AP, Pituru S, Diaconu CC, Parepa IR, Pantea
Stoian A, Pop CS and Suceveanu AI: Incidence of chemotherapy
induced peripheral neuropathy in cancer patients in clinical
practice. Farmacia. 66:904–908. 2018.
|
|
31
|
Boulton AJ, Vinik AI, Arezzo JC, Bril V,
Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM and Ziegler
D: American Diabetes Association. Diabetic neuropathies: A
statement by the American Diabetes Association. Diabetes Care.
28:956–962. 2005.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Gheorghe G, Stoian AP, Gaman M, Socea B,
Neagu TP, Stanescu AMA, Bratu OG, Mischianu DLD, Suceveanu AI and
Diaconu CC: The benefits and risks of antioxidant treatment in
liver diseases. Rev Chim. 70:651–655. 2019.
|
|
33
|
Stoian AP, Mitrofan G, Colceag F,
Suceveanu AI, Hainarosie R, Pituru S, Diaconu CC, Timofte D,
Nitipir C, Poiana C and Serafinceanu C: Oxidative stress in
diabetes. A model of complex thinking applied in medicine. Rev
Chim. 69:2515–2519. 2018.
|
|
34
|
Bromberg MB: An electrodiagnostic approach
to the evaluation of peripheral neuropathies. Phys Med Rehabil Clin
N Am. 24:153–168. 2013.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Verrotti A, Prezioso G, Scattoni R and
Chiarelli F: Autonomic neuropathy in diabetes mellitus. Front
Endocrinol (Lausanne). 5(205)2014.
|
|
36
|
Serhiyenko VA and Serhiyenko AA: Cardiac
autonomic neuropathy: Risk factors, diagnosis and treatment. World
J Diabetes. 9:1–24. 2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Vinik AI, Erbas T and Casellini CM:
Diabetic cardiac autonomic neuropathy, inflammation and
cardiovascular disease. J Diabetes Investig. 4:4–18.
2013.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Vinik AI and Ziegler D: Diabetic
cardiovascular autonomic neuropathy. Circulation. 115:387–397.
2007.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Gaman MA, Dobrica EC, Pascu EG, Cozma MA,
Epingeac ME, Gaman AM, Pantea Stoian AM, Bratu OG and Diaconu CC:
Cardio metabolic risk factors for atrial fibrillation in type 2
diabetes mellitus: Focus on hypertension, metabolic syndrome and
obesity. J Mind Med Sci. 6:157–161. 2019.
|
|
40
|
Yarandi SS and Srinivasan S: Diabetic
gastrointestinal motility disorders and the role of enteric nervous
system: Current status and future directions. Neurogastroenterol
Motil. 26:611–624. 2014.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Parkman HP, Yates K, Hasler WL, Nguyen L,
Pasricha PJ, Snape WJ, Farrugia G, Koch KL, Calles J, Abell TL, et
al: Similarities and differences between diabetic and idiopathic
gastroparesis. Clin Gastroenterol Hepatol. 9:1056–1064.
2011.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Yuan Z, Tang Z, He C and Tang W: Diabetic
cystopathy: A review. J Diabetes. 7:442–447. 2015.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Zaha DC, Kiss R, Hegedűs C, Gesztelyi R,
Bombicz M, Muresan M, Pallag A, Zrinyi M, Pall D, Vesa CM and Micle
O: Recent advances in investigation, prevention, and management of
healthcare-associated infections (HAIs): Resistant multidrug strain
colonization and its risk factors in an intensive care unit of a
university hospital. Biomed Res Int. 2019(2510875)2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Maiorino MI, Bellastella G and Esposito K:
Diabetes and sexual dysfunction: Current perspectives. Diabetes
Metab Syndr Obes. 7:95–105. 2014.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Sáenz de Tejada I, Angulo J, Cellek S,
González-Cadavid N, Heaton J, Pickard R and Simonsen U:
Pathophysiology of erectile dysfunction. J Sex Med. 2:26–39.
2005.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Rhoden EL, Telöken C, Sogari PR and Vargas
Souto CA: The use of the simplified international index of erectile
function (IIEF-5) as a diagnostic tool to study the prevalence of
erectile dysfunction. Int J Impot Res. 14:245–250. 2002.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Enzlin P, Rosen R, Wiegel M, Brown J,
Wessells H, Gatcomb P, Rutledge B, Chan KL and Cleary PA: DCCT/EDIC
Research Group. Sexual dysfunction in women with type 1 diabetes:
Long-term findings from the DCCT/EDIC study cohort. Diabetes Care.
32:780–785. 2009.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Pop-Busui R, Herman WH, Feldman EL, Low
PA, Martin CL, Cleary PA, Waberski BH, Lachin JM and Albers JW:
DCCT/EDIC Research Group. DCCT and EDIC studies in type 1 diabetes:
Lessons for diabetic neuropathy regarding metabolic memory and
natural history. Curr Diab Rep. 10:276–282. 2010.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Intensive blood-glucose control with
sulphonylureas or insulin compared with conventional treatment and
risk of complications in patients with type 2 diabetes (UKPDS 33).
UK prospective diabetes study (UKPDS) group. Lancet. 352:837–853.
1998.PubMed/NCBI
|
|
50
|
Boussageon R, Bejan-Angoulvant T,
Saadatian-Elahi M, Lafont S, Bergeonneau C, Kassaï B, Erpeldinger
S, Wright JM, Gueyffier F and Cornu C: Effect of intensive glucose
lowering treatment on all cause mortality, cardiovascular death,
and microvascular events in type 2 diabetes: Meta-analysis of
randomized controlled trials. BMJ. 343(d4169)2011.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Ramirez MA and Borja NL: Epalrestat: An
aldose reductase inhibitor for the treatment of diabetic
neuropathy. Pharmacotherapy. 28:646–655. 2008.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Sharma SR and Sharma N: Epalrestat, an
aldose reductase inhibitor, in diabetic neuropathy: An Indian
perspective. Ann Indian Acad Neurol. 11:231–235. 2008.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Chalk C, Benstead TJ and Moore F: Aldose
reductase inhibitors for the treatment of diabetic polyneuropathy.
Cochrane Database Syst Rev: CD004572, 2007.
|
|
54
|
Hu X, Li S, Yang G, Liu H, Boden G and Li
L: Efficacy and safety of aldose reductase inhibitor for the
treatment of diabetic cardiovascular autonomic neuropathy:
Systematic review and meta-analysis. PLoS One.
9(e87096)2014.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Vallianou N, Evangelopoulos A and Koutalas
P: Alpha-lipoic acid and diabetic neuropathy. Rev Diabet Stud.
6:230–236. 2009.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Nickander KK, McPhee BR, Low PA and
Tritschler H: Alpha-lipoic acid: Antioxidant potency against lipid
peroxidation of neural tissues in vitro and implications for
diabetic neuropathy. Free Radic Biol Med. 21:631–639.
1996.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Nagamatsu M, Nickander KK, Schmelzer JD,
Raya A, Wittrock DA, Tritschler H and Low PA: Lipoic acid improves
nerve blood flow, reduces oxidative stress, and improves distal
nerve conduction in experimental diabetic neuropathy. Diabetes
Care. 18:1160–1167. 1995.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Ziegler D, Hanefeld M, Ruhnau KJ, Meissner
HP, Lobisch M, Schütte K and Gries FA: Treatment of symptomatic
diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic
acid. A 3-week multicentre randomized controlled trial (ALADIN
Study). Diabetologia. 38:1425–1433. 1995.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Ruhnau KJ, Meissner HP, Finn JR,
Reljanovic M, Lobisch M, Schütte K, Nehrdich D, Tritschler HJ,
Mehnert H and Ziegler D: Effects of 3-week oral treatment with the
antioxidant thioctic acid (alpha-lipoic acid) in symptomatic
diabetic polyneuropathy. Diabet Med. 16:1040–1043. 1999.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Ametov AS, Barinov A, Dyck PJ, Hermann R,
Kozlova N, Litchy WJ, Low PA, Nehrdich D, Novosadova M, O'Brien PC,
et al: The sensory symptoms of diabetic polyneuropathy are improved
with alpha-lipoic acid: The SYDNEY trial. Diabetes Care.
26:770–776. 2003.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Ziegler D, Ametov A, Barinov A, Dyck PJ,
Gurieva I, Low PA, Munzel U, Yakhno N, Raz I, Novosadova M, et al:
Oral treatment with alpha-lipoic acid improves symptomatic diabetic
polyneuropathy: The SYDNEY 2 trial. Diabetes Care. 29:2365–2370.
2006.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Mijnhout GS, Kollen BJ, Alkhalaf A,
Kleefstra N and Bilo HJ: Alpha lipoic acid for symptomatic
peripheral neuropathy in patients with diabetes: A meta-analysis of
randomized controlled trials. Int J Endocrinol.
2012(456279)2012.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Han T, Bai J, Liu W and Hu Y: A systematic
review and meta-analysis of α-lipoic acid in the treatment of
diabetic peripheral neuropathy. Eur J Endocrinol. 167:465–471.
2012.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Pácal L, Kuricová K and Kaňková K:
Evidence for altered thiamine metabolism in diabetes: Is there a
potential to oppose gluco- and lipotoxicity by rational
supplementation? World J Diabetes. 5:288–295. 2014.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Thornalley PJ, Jahan I and Ng R:
Suppression of the accumulation of triosephosphates and increased
formation of methylglyoxal in human red blood cells during
hyperglycaemia by thiamine in vitro. J Biochem. 129:543–549.
2001.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Hammes HP, Du X, Edelstein D, Taguchi T,
Matsumura T, Ju Q, Lin J, Bierhaus A, Nawroth P, Hannak D, et al:
Benfotiamine blocks three major pathways of hyperglycemic damage
and prevents experimental diabetic retinopathy. Nat Med. 9:294–299.
2003.PubMed/NCBI View
Article : Google Scholar
|
|
67
|
Sánchez-Ramírez GM, Caram-Salas NL,
Rocha-González HI, Vidal-Cantú GC, Medina-Santillán R, Reyes-García
G and Granados-Soto V: Benfotiamine relieves inflammatory and
neuropathic pain in rats. Eur J Pharmacol. 530:48–53.
2006.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Haupt E, Ledermann H and Köpcke W:
Benfotiamine in the treatment of diabetic polyneuropathy-a
three-week randomized, controlled pilot study (BEDIP study). Int J
Clin Pharmacol Ther. 43:71–77. 2005.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Winkler G, Pál B, Nagybéganyi E, Ory I,
Porochnavec M and Kempler P: Effectiveness of different
benfotiamine dosage regimens in the treatment of painful diabetic
neuropathy. Arzneimittelforschung. 49:220–224. 1999.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Nikolić A, Kacar A, Lavrnić D, Basta I and
Apostolski S: The effect of benfothiamine in the therapy of
diabetic polyneuropathy. Srp Arh Celok Lek. 137:594–600.
2009.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Stracke H, Gaus W, Achenbach U, Federlin K
and Bretzel RG: Benfotiamine in diabetic polyneuropathy (BENDIP):
Results of a randomised, double blind, placebo-controlled clinical
study. Exp Clin Endocrinol Diabetes. 116:600–605. 2008.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Bril V, England J, Franklin GM, Backonja
M, Cohen J, Del Toro D, Feldman E, Iverson DJ, Perkins B, Russell
JW, et al: Evidence-based guideline: Treatment of painful diabetic
neuropathy: Report of the American academy of neurology, the
American association of neuromuscular and electrodiagnostic
medicine, and the American academy of physical medicine and
rehabilitation. Neurology. 76:1758–1765. 2011.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Attal N, Cruccu G, Baron R, Haanpää M,
Hansson P, Jensen TS and Nurmikko T: European Federation of
Neurological Societies. EFNS guidelines on the pharmacological
treatment of neuropathic pain: 2010 revision. Eur J Neurol.
17:1113–e88. 2010.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Goldstein DJ, Lu Y, Detke MJ, Lee TC and
Iyengar S: Duloxetine vs. placebo in patients with painful diabetic
neuropathy. Pain. 116:109–118. 2005.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Ormseth MJ, Scholz BA and Boomershine CS:
Duloxetine in the management of diabetic peripheral neuropathic
pain. Patient Prefer Adherence. 5:343–356. 2011.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Gilron I, Bailey JM, Tu D, Holden RR,
Weaver DF and Houlden RL: Morphine, gabapentin, or their
combination for neuropathic pain. N Engl J Med. 352:1324–1334.
2005.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Rosenstock J, Tuchman M, LaMoreaux L and
Sharma U: Pregabalin for the treatment of painful diabetic
peripheral neuropathy: A double-blind, placebo-controlled trial.
Pain. 110:628–638. 2004.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Wiffen P, Collins S, McQuay H, Carroll D,
Jadad A and Moore A: Anticonvulsant drugs for acute and chronic
pain. Cochrane Database Syst Rev. (CD001133)2000.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Hossain SM, Hussain SM and Ekram AR:
Duloxetine in painful diabetic neuropathy: A systematic review.
Clin J Pain. 32:1005–1010. 2016.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Harati Y, Gooch C, Swenson M, Edelman S,
Greene D, Raskin P, Donofrio P, Cornblath D, Sachdeo R, Siu CO and
Kamin M: Double-blind randomized trial of tramadol for the
treatment of the pain of diabetic neuropathy. Neurology.
50:1842–1846. 1998.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Freeman R, Raskin P, Hewitt DJ, Vorsanger
GJ, Jordan DM, Xiang J and Rosenthal NR: CAPSS-237 Study Group.
Randomized study of tramadol/acetaminophen versus placebo in
painful diabetic peripheral neuropathy. Curr Med Res Opin.
23:147–161. 2007.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Ghita MA, Caruntu C, Lixandru D, Pitea A,
Batani A and Boda D: The quest for novel biomarkers in early
diagnosis of diabetic neuropathy. Curr Proteomics. 14:86–99.
2017.
|
|
83
|
Caruntu C, Negrei C, Boda D, Constantin C,
Caruntu A and Neagu M: Biotechnological advances for diagnosis of
peripheral diabetic neuropathy. Rom Biotechnol Lett. 19:9846–9858.
2014.
|
|
84
|
Alsaloum M, Estacion M, Almomani R,
Gerrits MM, Bönhof GJ, Ziegler D, Malik R, Ferdousi M, Lauria G,
Merkies IS, et al: A gain-of-function sodium channel β2-subunit
mutation in painful diabetic neuropathy. Mol Pain.
15(1744806919849802)2019.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Mendelson WB: A review of the evidence for
the efficacy and safety of trazodone in insomnia. J Clin
Psychiatry. 66:469–476. 2005.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Keppel Hesselink JM and Schatman ME:
EMA401: An old antagonist of the AT2R for a new indication in
neuropathic pain. J Pain Res. 10:439–443. 2017.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Tesfaye S: PL37: A new hope in the
treatment of painful diabetic neuropathy? Pain Manag. 6:129–132.
2016.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Ghadiri-Anari A, Mozafari Z, Gholami S,
Khodaei SA, Aboutorabi-Zarchi M, Sepehri F, Nadjarzade A, Rahmanian
M and Namiranian N: Dose vitamin D supplementations improve
peripheral diabetic neuropathy? A before-after clinical trial.
Diabetes Metab Syndr. 13:890–893. 2019.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Căruntu C, Negrei C, Ghiţă MA, Căruntu A,
Bădărău AI, Buraga I, Boda D, Albu A and Brănişteanu D: Capsaicin,
a hot topic in skin pharmacology and physiology. Farmacia.
63:487–491. 2015.
|
|
90
|
Căruntu C and Boda D: Evaluation through
in vivo reflectance confocal microscopy of the cutaneous neurogenic
inflammatory reaction induced by capsaicin in human subjects. J
Biomed Opt. 17(085003)2012.PubMed/NCBI View Article : Google Scholar
|
